Jason Thonhoff

Company: Coya Therapeutics

Job title: Head of Clinical Development

Seminars:

Modulating the TREGs Pathway in ALS: Unveiling Innate Immunity’s Role in Neurodegeneration 1:30 pm

Understanding regulatory T cells (TREGs) and their role in contributing to neuroinflammation and neurodegeneration via adaptive and immune cell activation in ALS Exploring efficacy in targeting CD40L to increase the polarization of lymphocytes in TREGs upstream to suppress neuroinflammation inducing neuroprotection and restoring function in ALS patients Unveiling new interim Phase 2 trial results to…Read more

day: Conference Day Two Track B PM